Ipilimumab vs Pantoprazole
Ipilimumab vs Pantoprazole: Overview
This comparison examines the pharmacological differences between Ipilimumab and Pantoprazole.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pantoprazole: Proton pump inhibitor.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Pantoprazole β 1 hour.
Chemical Properties
Molecular Formula: Pantoprazole β C16H15F2N3O4S.
Molecular Weight: Pantoprazole β 383.3710 g/mol.
Type: Ipilimumab β Antibody; Pantoprazole β Small molecule.